Log in

OTCMKTS:RGDXQ - Response Genetics Stock Price, Forecast & News

$0.0034
0.00 (0.00 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.01
Volume21,000 shs
Average Volume170,768 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.39
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RGDXQ
Previous SymbolNASDAQ:RGDX
CUSIPN/A
Phone323-224-3900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees96
Next Earnings DateN/A
OptionableNot Optionable

Receive RGDXQ News and Ratings via Email

Sign-up to receive the latest news and ratings for RGDXQ and its competitors with MarketBeat's FREE daily newsletter.


Response Genetics (OTCMKTS:RGDXQ) Frequently Asked Questions

What is Response Genetics' stock symbol?

Response Genetics trades on the OTCMKTS under the ticker symbol "RGDXQ."

Has Response Genetics been receiving favorable news coverage?

Media coverage about RGDXQ stock has trended extremely negative on Saturday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Response Genetics earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Response Genetics.

Who are some of Response Genetics' key competitors?

What other stocks do shareholders of Response Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Response Genetics investors own include Capstone Turbine (CPST), Cytori Therapeutics (CYTX), RF Micro Devices (RFMD), SLS International (SLS), Cimic Group (CIM), Acer Therapeutics (ACER), AEterna Zentaris (AEZS), Agenus (AGEN), Arena Pharmaceuticals (ARNA) and Assembly Biosciences (ASMB).

Who are Response Genetics' key executives?

Response Genetics' management team includes the folowing people:
  • Thomas A. Bologna, Chairman of the Board, Chief Executive Officer (Age 66)
  • Kevin Roy Harris, Chief Financial Officer, Vice President (Age 47)
  • Adanech Getachew, General Counsel (Age 37)
  • Kirk K. Calhoun, Lead Independent Director (Age 73)
  • Michael Serruya, Director (Age 51)
  • Sam Chawla, Independent Director (Age 41)
  • David R Schreiber, Independent Director (Age 55)
  • Richard A. van den Broek, Independent Director (Age 49)

How do I buy shares of Response Genetics?

Shares of RGDXQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Response Genetics' stock price today?

One share of RGDXQ stock can currently be purchased for approximately $0.00.

What is Response Genetics' official website?

The official website for Response Genetics is http://www.responsegenetics.com/.

How can I contact Response Genetics?

Response Genetics' mailing address is 1640 MARENGO ST 7TH FLOOR, LOS ANGELES CA, 90033. The medical research company can be reached via phone at 323-224-3900 or via email at [email protected]


MarketBeat Community Rating for Response Genetics (OTCMKTS RGDXQ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about Response Genetics and other stocks. Vote "Outperform" if you believe RGDXQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RGDXQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel